Siponimod, sold under the brand name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS). It is intended for once-daily oral administration.
via PubMed
{{Infobox drug | image = Siponimod.svg | image_class = skin-invert-image | width = 275 | alt = | caption =
| pronounce = | tradename = Mayzent | Drugs.com = | MedlinePlus = a619027 | DailyMedID = Siponimod | pregnancy_AU = D | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATCvet = | ATC_prefix = L04 | ATC_suffix = AE03 | ATC_supplemental =
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).